Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07824024) titled 'A Phase III Study of Hemofence for Hemostasis in Patients With Uncontrolled Exudative Hemorrhage During Spinal Or Orthopedic Surgery' on Sept. 11.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Participant).
Primary Sponsor: BMI Korea
Condition:
Surgical Hemorrhage
Intervention:
Drug: Hemofence
Recruitment Status: Not recruiting
Phase: Phase 3
Date of First Enrollment: December 3, 2020
Target Sample Size: 172
Countries of Recruitment:
South Korea
To know more, visit https://clinicaltrials.gov/study...